The EMA has launched a consultation on the circumstances in which single-arm trials (SATs) – those without a control group – can be used to support marketing applications for medicines…
First, the market is recovering, and the industry is gaining momentum in the second year of the major war. Thus, sales of medicines in the first half of 2023 increased…